Training & Onboarding Scheduler at Legend Biotech

Ghent, Flanders, Belgium

Legend Biotech Logo
Not SpecifiedCompensation
Junior (1 to 2 years)Experience Level
Full TimeJob Type
UnknownVisa
BiotechnologyIndustries

Requirements

  • Bachelor degree or equivalent through work experience
  • At least a first relevant experience
  • Fluent in English and Dutch, with strong written and oral communication skills
  • Highly organized and capable of prioritizing and multitasking
  • Good understanding of Excel and a problem-solving mindset
  • Eye for detail and strong planning skills

Responsibilities

  • Use Office package (Outlook, Excel, etc.) to schedule and keep an overview of ongoing trainings and onboardings, ensuring no overlaps and efficiency for trainers and trainees
  • Assist on onboarding days: ensure the right people are informed and in place
  • Adapt planning when things change and communicate clearly with colleagues, trainers, and others

Skills

Excel
Outlook
Microsoft Office
Scheduling
Planning
Communication
Multitasking
Problem-solving
English
Dutch

Legend Biotech

Develops and commercializes cell therapies

About Legend Biotech

Legend Biotech develops and commercializes cell therapies aimed at treating serious diseases, particularly cancers like hematological malignancies and solid tumors. Their approach is technology agnostic, allowing them to explore various methods to find effective treatments. The company operates in the personalized medicine sector, focusing on discovering, developing, and bringing new therapies to market. They generate revenue through licensing and selling their therapies, including CAR-T therapies, which involve modifying a patient's cells to combat cancer. Legend Biotech emphasizes transparency with investors, regularly updating them on financial results and business developments.

Franklin Township, New JerseyHeadquarters
2014Year Founded
$146.4MTotal Funding
IPOCompany Stage
Biotechnology, HealthcareIndustries
1,001-5,000Employees

Benefits

Health Insurance
Dental Insurance
Vision Insurance
Life Insurance
Disability Insurance
Paid Sick Leave
Paid Holidays
Remote Work Options

Risks

Increased competition from Amgen's Imdelltra may impact CAR-T therapy focus.
Collaboration with Multiply Labs may face technological challenges, delaying production timelines.
Financial strain from new R&D facility could affect operational focus if advancements lag.

Differentiation

Legend Biotech focuses on novel cell therapies for oncology, including CAR-T and NK cells.
The company is technology agnostic, exploring multiple platforms for effective cancer treatments.
Legend Biotech's CARVYKTI® is the first BCMA-targeted CAR-T therapy approved for second-line use.

Upsides

Recent FDA and European approvals for CARVYKTI® expand its market reach in multiple myeloma.
New R&D facility in Philadelphia boosts innovation in next-generation cell therapies.
Alan Bash's appointment could accelerate CARVYKTI®'s growth and market penetration.

Land your dream remote job 3x faster with AI